Kirr Marbach & Co’s BioTelemetry, Inc. BEAT Stock Holding History

Kirr Marbach & Co’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-19,399	Closed	-$1.4M	–	62
2020 Q4	$1.4M	Sell	19,399 -18,799	-49%	-$984K	0.44%	39
2020 Q3	$1.74M	Sell	38,198 -1,477	-4%	-$61.7K	0.65%	38
2020 Q2	$1.79M	Buy	39,675 +33	+0.1%	+$1.48K	0.64%	40
2020 Q1	$1.53M	Sell	39,642 -24,426	-38%	-$1.12M	0.65%	42
2019 Q4	$2.97M	Buy	+64,068	New	+$2.77M	0.69%	42

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Kirr Marbach & Co's BEAT Position: Q1 2021 in Review

Kirr Marbach & Co sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 19,399 shares — an estimated $1.4M sold.

Kirr Marbach & Co first reported a position in BEAT in Q4 2019 and held it in 5 quarters. The position peaked at $2.97M in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Kirr Marbach & Co reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Kirr Marbach & Co sold 19,399 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.4M.
Kirr Marbach & Co first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 5 quarters.
Kirr Marbach & Co's BioTelemetry, Inc. position peaked at $2.97M in Q4 2019.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Kirr Marbach & Co's 13F filing for Q1 2021, filed 19 Apr 2021.